Adamas Pharmaceuticals Inc (ADMS)
Common Stock
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.70M | -57.40M | -105.19M | -131.00M | -89.49M | |||
| Depreciation Amortization | 600.00K | 850.00K | 1.21M | 1.46M | 1.19M | |||
| Change In Working Capital | -5.94M | -15.20M | -5.17M | -9.75M | 3.30M | |||
| Interest Paid | N/A | 11.74M | 6.45M | 2.62M | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 21.23M | 21.04M | 28.37M | 35.07M | 18.17M | |||
| OPERATING CASH FLOW | -46.82M | -50.71M | -80.78M | -104.22M | -66.83M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -20.00K | -1.06M | -1.26M | |||
| Other Investing Activity | 7.88M | 54.94M | 88.88M | -68.27M | 26.82M | |||
| INVESTING CASH FLOW | 7.84M | 54.94M | 88.86M | -69.34M | 25.57M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.66M | 0.00 | 0.00 | 0.00 | 99.60M | |||
| Stock Issued/Repurchased | 68.44M | 1.65M | 1.09M | 138.85M | 9.88M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | -630.00K | |||
| FINANCING CASH FLOW | 66.78M | 1.65M | 1.09M | 138.85M | 108.84M | |||
| CHANGE IN CASH | 27.81M | 5.88M | 9.17M | -34.71M | 67.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -46.82M | -50.71M | -80.78M | -104.22M | -66.83M | |||
| Capital Expenditure | N/A | 0.00 | -20.00K | -1.06M | -1.26M | |||
| FREE CASH FLOW | N/A | -50.71M | -80.80M | -105.28M | -68.09M | |||
All data in USD